Boston Scientific reports positive Q2 results yet opts to trim 2026 outlook
Boston's tempered 2026 outlook is likely due in part to its recently announced plans to initiate a global restructuring programme.
Boston's tempered 2026 outlook is likely due in part to its recently announced plans to initiate a global restructuring programme.
The National Healthtech Access Programme aims to improve accessibility to healthtech products across the NHS.
The medical devices industry continues to be a hotbed of patent innovation. Activity is driven by increased need for homecare,...
Intuitive Surgical expands platforms despite market headwind
The increased importance of safety for wearable devices
What does the EU Data Act mean for businesses?
GE HealthCare launches new ultrasound system for cardiovascular imaging